The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
The move, which is not supported by the pharmaceutical industry, would allow other countries to design and manufacture COVID-19 vaccines without fear of litigation.
Administration officials and lawmakers say the move is to shore up national security threats, but university professors argue such cancellations represent targeted discrimination.
Changing policy has left academics uncertain about what is legal for foreign involvement in research, and increased hostility and bureaucracy have led students and scholars to seek opportunities elsewhere.
A Michigan University clinical researcher allegedly supplied a fund manager with information about drug trial results that the fund used to rake in more than $270 million.